BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 89 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $480,880 | -53.6% | 28,778 | -57.2% | 0.00% | 0.0% |
| Q4 2022 | $1,036,880 | +0.2% | 67,199 | -3.1% | 0.00% | 0.0% |
| Q3 2022 | $1,035,000 | -28.2% | 69,345 | -20.9% | 0.00% | -50.0% |
| Q2 2022 | $1,441,000 | -17.1% | 87,692 | +1.2% | 0.00% | 0.0% |
| Q1 2022 | $1,739,000 | -14.3% | 86,674 | +8.3% | 0.00% | 0.0% |
| Q4 2021 | $2,029,000 | -4.2% | 80,020 | +2.0% | 0.00% | 0.0% |
| Q3 2021 | $2,118,000 | -5.4% | 78,488 | +1.4% | 0.00% | 0.0% |
| Q2 2021 | $2,239,000 | +12.7% | 77,412 | +2.5% | 0.00% | 0.0% |
| Q1 2021 | $1,987,000 | -7.0% | 75,553 | +1.3% | 0.00% | -33.3% |
| Q4 2020 | $2,137,000 | +61.9% | 74,580 | +34.8% | 0.00% | +50.0% |
| Q3 2020 | $1,320,000 | +66.5% | 55,331 | +45.8% | 0.00% | +100.0% |
| Q2 2020 | $793,000 | – | 37,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EPIQ PARTNERS, LLC | 169,250 | $4,451,000 | 2.55% |
| Cornerstone Advisors, LLC | 459,157 | $12,076,000 | 1.06% |
| Matisse Capital | 250,000 | $6,574,000 | 0.95% |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 45,356 | $1,193,000 | 0.94% |
| 1607 Capital Partners, LLC | 423,925 | $11,149,000 | 0.54% |
| Thomas J. Herzfeld Advisors, Inc. | 33,722 | $887,000 | 0.40% |
| KAVAR CAPITAL PARTNERS GROUP, LLC | 39,750 | $1,045,000 | 0.28% |
| Stockman Wealth Management, Inc. | 20,296 | $534,000 | 0.15% |
| Karpus Management, Inc. | 186,631 | $4,908,000 | 0.15% |
| CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | 100,211 | $2,631,000 | 0.14% |